LexDanaLexDanabeta
Inventor

Oliver L. Saunders

Inventor
San Mateo, CA, US

Overview

24→
Patents
2003–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds20%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium18%
A61KPreparations for medical, dental or toiletry purposes16%
C07HSugars13%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
10,988,498Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs202110,428,105Alkynyl nucleoside analogs as inhibitors of human rhinovirus201910,023,600Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs20189,988,416Alkynyl nucleoside analogs as inhibitors of human rhinovirus20189,957,275Pyrazolo[1,5-A]pyrimidines for antiviral treatment2018RE046762'1′-substituted carba-nucleoside analogs for antiviral treatment'20189,814,739'2′-ethynyl nucleoside derivatives for treatment of viral infections'20179,556,216'2′-Ethynyl nucleoside derivatives for treatment of viral infections'20179,238,039'Pyrazolo[1,5-A]pyrimidines for antiviral treatment'20168,853,171'1′-substituted carba-nucleoside analogs for antiviral treatment'20148,809,330'Pyrazolo[1,5-A]pyrimidines for antiviral treatment'20148,486,938'Pyrazolo[1,5-a]pyrimidines for antiviral treatment'20138,324,179'Nucleoside analogs for antiviral treatment'20128,318,682'1′substituted carba-nucleoside analogs for antiviral treatment'20128,034,959'Methods of treating cancer with an antibody-drug conjugate'20118,008,264'1′-substituted carba-nucleoside analogs for antiviral treatment'20117,977,465'Peptidyl prodrugs and linkers and stabilizers useful therefor'20117,842,672'Phosphonate inhibitors of HCV'20107,507,420'Peptidyl prodrugs and linkers and stabilizers useful therefor'20097,498,302'Disulfide prodrugs and linkers and stabilizers useful therefor'20097,129,261'Cytotoxic agents'20067,087,600'Peptidyl prodrugs and linkers and stabilizers useful therefor'20066,989,452'Disulfide prodrugs and linkers and stabilizers useful therefor'20066,576,630'Compounds and compositions as protease inhibitors'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2011Based in Burlingame, CA, US· patent location history
2006–2011Patents assigned to MEDAREX INC (7)· patent assignee history
2010–2021Patents assigned to GILEAD SCIENCES INC (12)· patent assignee history
2010–2021Based in San Mateo, CA, US· patent location history
2012–2018Patents assigned to SAUNDERS OLIVER L (4)· patent assignee history
2012–2018Patents assigned to BUTLER THOMAS (2)· patent assignee history
2017–2019Patents assigned to NOVARTIS AG (4)· patent assignee history
2018–2019Based in Clovis, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC122010–2021
MEDAREX INC72006–2011
NOVARTIS AG42017–2019
SAUNDERS OLIVER Lself42012–2018
BUTLER THOMAS22012–2018
Locations
LocationPatentsSpan
San Mateo, California, US122010–2021
Burlingame, California, US82003–2011
Clovis, California, US42018–2019